<DOC> 
<DOCNO>1040724_business_story_3536283.utf8</DOCNO> 
<TEXT> 

The Telegraph - Calcutta : Business
 Saturday, July 24, 2004 				 Retail loans fuel ICICI Bank net gains
 OUR SPECIAL CORRESPONDENT 																								Mumbai, July 23: ICICI Bank has reported a 26.76 per cent rise in net profit at Rs 431 crore in the first quarter ended June 30, 2004, from Rs 340 crore in the same quarter of 2003-04. The bottomline was fuelled by strong performance in its retail business.																								Total income, however, declined to Rs 2,853.49 crore from Rs 2,938.55 crore last year. Treasury income also dropped 64 per cent to Rs 93 crore from Rs 261 crore year-on-year.																								Net interest income shot up 39 per cent to Rs 631 crore from Rs 455 crore and fee income rose 77 per cent to Rs 418 crore (Rs 235 crore). Core operating income increased 43 per cent to Rs 1,196 crore (Rs 838 crore).																								The countrys second largest bank disbursed home loans worth Rs 3,855 crore in the April-June period. Retail assets constituted 56 per cent of advances and 50 per cent of customer assets.																								Its net non-performing assets constituted 2.7 per cent of customer assets against 4.9 per cent in the year-ago period. The banks capital adequacy ratio increased to 15.21 per cent from 9.36 per cent. 																								Consolidated net profit stood at Rs 400 crore in the April-June quarter against Rs 337 crore a year ago and total income was Rs 3,500.49 crore compared with Rs 3251.34 crore in the previous corresponding period. 																								The Reserve Bank of India has approved the boards recommendation of 75 per cent dividend for 2003-04 and the record date for the same has been fixed as September 4.Cipla net up 18%																								Cipla Ltd has registered a 17.93 per cent rise in net profit at Rs 79.26 crore for the first quarter ended June 30 compared with Rs 67.2 crore in the year-ago period.																								Total income increased to Rs 580.13 crore during the quarter from Rs 460.91 crore in the year-ago period, the company informed the Bombay Stock Exchange today.																								For the financial year ended March 31, 2004, net profit and total income of the drug major was reported at Rs 295.59 crore (Rs 247.74) and Rs 2,090.99 crore (Rs 1,599 crore) respectively.
</TEXT> 
</DOC>